StockData
Biomerica Inc logo

Biomerica Inc (BMRA) stock

BMRANasdaqIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends May 31
Financials through Q1 FY2027, quarter ended Aug 31, 2026Last filing: 10-Q on Oct 15, 2026Score 8/3055% below fair value
$1.08−0.02 (-1.82%)

Close on Nov 20, 2026Market cap $4.97MP/E –Yield –

Biomerica shares outstanding

Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.

Biomerica's shares outstanding was 3M at Aug 31, 2026. For fiscal 2026 it was 3M, up 26.9% from the year before. Over ten years it grew 11.8% a year on average. The highest annual figure on record is 3M in fiscal 2026.

Annual shares outstanding

PeriodPeriod endValueChange
FY2026May 31, 20263M+26.9%
FY2025May 31, 20252M+9.2%
FY2024May 31, 20242M+18.9%
FY2023May 31, 20232M+11.7%
FY2022May 31, 20222M+6.2%
FY2021May 31, 20211M+17.3%
FY2020May 31, 20201M+10.4%
FY2019May 31, 20191M+7.5%
FY2018May 31, 20181M+2.9%
FY2017May 31, 20171M+9.2%
FY2016May 31, 20161M+1.0%
FY2015May 31, 20151M+2.5%
FY2014May 31, 20141M-1.1%
FY2013May 31, 20131M+4.8%
FY2012May 31, 20121M+6.0%
FY2011May 31, 20111M–

Quarterly shares outstanding

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q1 FY2027CQ3 2026Aug 31, 20263M+24.9%
Q4 FY2026CQ2 2026May 31, 20263M+40.6%
Q3 FY2026CQ1 2026Feb 28, 20263M+25.5%
Q2 FY2026CQ4 2025Nov 30, 20253M+35.9%
Q1 FY2026CQ3 2025Aug 31, 20253M+25.5%
Q4 FY2025CQ2 2025May 31, 20252M+4.9%
Q3 FY2025CQ1 2025Feb 28, 20252M+14.1%
Q2 FY2025CQ4 2024Nov 30, 20242M+1.8%
Q1 FY2025CQ3 2024Aug 31, 20242M+0.0%
Q4 FY2024CQ2 2024May 31, 20242M+1.5%
Q3 FY2024CQ1 2024Feb 29, 20242M+24.8%
Q2 FY2024CQ4 2023Nov 30, 20232M+25.0%
Q1 FY2024CQ3 2023Aug 31, 20232M+28.4%
Q4 FY2023CQ2 2023May 31, 20232M+29.1%
Q3 FY2023CQ1 2023Feb 28, 20232M+5.2%
Q2 FY2023CQ4 2022Nov 30, 20222M+6.9%
Q1 FY2023CQ3 2022Aug 31, 20222M+5.4%
Q4 FY2022CQ2 2022May 31, 20222M+4.5%
Q3 FY2022CQ1 2022Feb 28, 20222M+7.7%
Q2 FY2022CQ4 2021Nov 30, 20212M+7.1%
Q1 FY2022CQ3 2021Aug 31, 20212M+5.8%
Q4 FY2021CQ2 2021May 31, 20212M+11.7%
Q3 FY2021CQ1 2021Feb 28, 20211M+21.3%
Q2 FY2021CQ4 2020Nov 30, 20201M+19.7%
Q1 FY2021CQ3 2020Aug 31, 20201M+20.6%
Q4 FY2020CQ2 2020May 31, 20201M+15.5%
Q3 FY2020CQ1 2020Feb 29, 20201M+5.3%
Q2 FY2020CQ4 2019Nov 30, 20191M+8.3%
Q1 FY2020CQ3 2019Aug 31, 20191M+9.1%
Q4 FY2019CQ2 2019May 31, 20191M+9.7%
Q3 FY2019CQ1 2019Feb 28, 20191M+9.0%
Q2 FY2019CQ4 2018Nov 30, 20181M+6.4%
Q1 FY2019CQ3 2018Aug 31, 20181M+4.9%
Q4 FY2018CQ2 2018May 31, 20181M+2.2%
Q3 FY2018CQ1 2018Feb 28, 20181M+1.5%
Q2 FY2018CQ4 2017Nov 30, 20171M+4.0%
Q1 FY2018CQ3 2017Aug 31, 20171M–
Q4 FY2017CQ2 2017May 31, 20171M–
Q3 FY2017CQ1 2017Feb 28, 20171M–
Q2 FY2017CQ4 2016Nov 30, 20161M–

More Biomerica figures

See a number that looks wrong?